🔎 Trials Near Me

Beranda › Kanker Prostat › Delaware › Newark

Uji klinis Kanker Prostat di Newark, DE

10 studi untuk Kanker Prostat mencari peserta di lokasi sekitar Newark (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Menerima pesertaFase 1/2
  • Medical Oncology Hematology Consultants, Newark
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04585750

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Menerima pesertaFase 3
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
Usia 18 ke atas · Pria · Diperbarui 2 Okt 2026 · NCT07200830

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Menerima pesertaFase 2
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06632977

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Menerima pesertaFase 3
  • Medical Oncology Hematology Consultants Helen F Graham Cancer Center, Newark
Usia 18 ke atas · Pria · Diperbarui 22 Sep 2026 · NCT07213674

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Menerima pesertaFase 3
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
Usia 18 ke atas · Pria · Diperbarui 10 Sep 2026 · NCT05946213

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Menerima pesertaFase 3
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
  • Christiana Care Health System-Christiana Hospital, Newark
  • dan 1 lainnya
Usia 18 ke atas · Pria · Diperbarui 14 Jul 2026 · NCT06592924

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

Menerima pesertaFase 3
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
  • Christiana Care Health System-Christiana Hospital, Newark
  • dan 1 lainnya
Usia 18 ke atas · Pria · Diperbarui 22 Jan 2026 · NCT06470243

Vitamin D for Prostate Endocrine Therapy

Menerima pesertaFase 3
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
Usia 50 ke atas · Pria · Diperbarui 15 Jan 2026 · NCT05838716

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Newark
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Menerima pesertaFase 3
  • Helen F Graham Cancer Center, Newark
  • Christiana Care Health System-Christiana Hospital, Newark
Usia 18 ke atas · Pria · Diperbarui 11 Sep 2025 · NCT03678025

Uji klinis Kanker Prostat di kota lain

Studi lain di Newark

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.